LYTTON LAURENCE W 13D and 13G filings for Paratek Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-13 3:40 pm Sale |
2022-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
LYTTON LAURENCE W | 459,961 0.800% |
-2,750,591![]() (-85.67%) |
Filing |
2022-05-18 4:47 pm Purchase |
2022-05-09 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
LYTTON LAURENCE W | 3,210,552 5.900% |
3,210,552![]() (New Position) |
Filing |